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Progressive supranuclear palsy (PSP) is the sec-
ond most common neurodegenerative extrapyrami-
dal disorder after idiopathic Parkinson’s disease (PD) 
Globose neurofi brillary tangles (NFTs), tau positive 
astrocytes, and occasional ballooned argyrophilic 
neuronal degeneration involving brainstem, basal 
ganglia, and frontal lobe represent the pathological 
hallmarks of PSP. Th e cardinal clinical features of 
PSP are an insidious early onset of a symmetric aki-
netic-rigid syndrome with vertical supranuclear gaze 
palsy, early backwards falls, and frontal dysfunction. 
Magnetic resonance imaging (MRI) usually shows 
third ventricle dilatation and signifi cant midbrain 
atrophy especially of the anteroposterior diameter. 
Th e classic clinical description of PSP, however, does 
not adequately describe one-third of cases in patho-
logically confi rmed series. Patients with normal eye 
movements, or PD-like presentation with asymmet-
rical onset and good response to levodopa (L-dopa), 
have been described. Despite the publication of con-
sensus operational criteria, an accurate diagnosis of 
PSP remains indeed a challenge for each neurologist. 
Particular clinical and pathological overlap exist be-
tween PSP and cirtocobasal degeneration.
In an attempt to unravel these diagnostic diffi  cul-
ties, PSP has been recently classifi ed into two major 
clinical entities. Th e most common form is the clas-
sic clinical picture originally described by Richard-
son (Richardson’s syndrome or PSP-RS). Th e second 
clinical phenotype associated with PSP is the PSP-
parkinsonism (PSP-P), in which parkinsonism domi-
nates the early clinical picture with initial moderate 
response to L-dopa, falls are delayed, and if gaze palsy 
and dementia develop, they occur late in the course 
of the disease. Disease duration in PSP-RS is signifi -
cantly shorter and age at death earlier than in PSP-P. 
Pathological and genetic heterogeneity of PSP syn-
dromes has also been reported. Tau pathology is more 
severe and the eff ect of the H1/H1 PSP susceptibility 
genotype appears stronger in clinically defi ned PSP-
RS than in PSP-P. 
